Indra Sistemas, S.A. Market Share Analysis

Publisher Name :
Date:12-Dec-2012
No. of pages: 36
Inquire Before Buying

Indra Sistemas, S.A. Market Share Analysis

Summary

GlobalData’s new report, “Indra Sistemas, S.A. Market Share Analysis” provides in-depth information on Indra Sistemas, S.A..’s market position in the clinical IT systems market. The report also provides data and information on the overall competitive landscape within the clinical IT systems market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the clinical IT systems market.
- Indra Sistemas, S.A..’s company shares (in Revenues) information for all the key countries the company has presence in -Spain.
- Indra Sistemas, S.A..’s company shares (in Revenues) information for the clinical IT systems market.
- All the key data-points are for 2011 and cover all the key regions -Europe.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Indra Sistemas, S.A..’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Indra Sistemas, S.A..’s market positions.

Indra Sistemas, S.A. Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
3 Definitions of Markets/Categories Covered 6
3.1 Healthcare IT 6
3.1.1 Clinical IT Systems 6
4 Company Snapshot 7
4.1 Key facts 7
4.2 Company Overview 7
4.3 Financial Performance 7
4.4 SWOT Snapshot 7
4.5 Business Overview 8
4.6 Major Products and Services 9
4.6.1 Overview 9
5 History 10
6 SWOT Analysis 14
6.1 Overview 14
6.2 Indra Sistemas, S.A. Strengths 14
6.2.1 Comprehensive Range of Services 14
6.2.2 Innovative Solutions 15
6.2.3 Global Presence 15
6.3 Indra Sistemas, S.A. Weaknesses 15
6.3.1 Limited Liquidity 15
6.3.2 Increasing Debt 15
6.4 Indra Sistemas, S.A. Opportunities 16
6.4.1 Expansion through Acquisitions 16
6.4.2 Global Outlook for IT Services Market 16
6.4.3 Positive Outlook for Global Outsourcing Market 16
6.5 Indra Sistemas, S.A. Threats 17
6.5.1 Intense Competition 17
6.5.2 Rapid Technological Changes 17
6.5.3 Economic Downturn 17
7 Competitors 18
8 Competitive Landscape 20
8.1 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 20
8.2 Indra Sistemas, S.A., Healthcare IT (Clinical IT Systems), by Region, Market Share (2011) 22
8.3 Indra Sistemas, S.A., Healthcare IT (Clinical IT Systems), by Country, Market Share (2011) 23
9 Key Employees 24
10 Key Employee Biographies 25
11 Company Statement 26
12 Locations And Subsidiaries 28
12.1 Head Office 28
12.2 Other Locations & Subsidiaries 28
13 Appendix 31
13.1 Research Methodology 32
13.2 Secondary Research 32
13.3 Primary Research 33
13.4 Models 33
13.5 Forecasts 33
13.6 Expert Panels 34
13.7 GlobalData Consulting 34
13.8 Currency Conversion 35
13.9 Contact Us 36
13.10 Disclaimer 36

1.1 List of Tables
Table 1: Indra Sistemas, S.A., Key Facts, 2011 7
Table 2: Indra Sistemas, S.A., SWOT Analysis, 2011 14
Table 3: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 21
Table 4: Indra Sistemas, S.A., Healthcare IT (Clinical IT Systems), by Region, Revenue ($m) and Market Share (%), 2011 22
Table 5: Indra Sistemas, S.A., Healthcare IT (Clinical IT Systems), by Country, Revenue ($m) and Market Share (%), 2011 23
Table 6: Indra Sistemas, S.A., Key Employees 24
Table 7: Indra Sistemas, S.A., Other Locations 28
Table 8: Indra Sistemas, S.A., Subsidiaries 30
Table 9: USD to Local Currency, Average Exchange Rate, 2011 35

1.2 List of Figures
Figure 1: Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 20
  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • 2014 Deep Research Report on Global and China Intravenous Catheter Industry
    Published: 22-Jul-2014        Price: US $2200 Onwards        Pages: 184
    This is a professional and depth research report on China Intravenous Catheter industry. The report firstly introduced Intravenous Catheter basic information included Intravenous Catheter definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Intravenous Catheter industry policy and plan, Intravenous Catheter product specification, man......
  • 2014 Deep Research Report on Global and China Particulate Respirators Industry
    Published: 19-Jul-2014        Price: US $2200 Onwards        Pages: 150
    This is a professional and depth research report on Global and China Particulate Respirators industry. The report firstly introduced Particulate Respirators basic information included Particulate Respirators definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Particulate Respirators industry policy and plan, Particulate Respirators product specif......
  • 2014 Deep Research Report on Global and China Sialic Acid Industry
    Published: 19-Jul-2014        Price: US $2200 Onwards        Pages: 136
    This is a professional and depth research report on Global and China Sialic Acid industry. The report firstly introduced Sialic Acid basic information included Sialic Acid definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Sialic Acid industry policy and plan, Sialic Acid product specification, manufacturing process, cost structure etc. then sta......
  • OpportunityAnalyzer: Dengue Vaccines – Opportunity Analysis and Forecasts to 2020
    Published: 17-Jul-2014        Price: US $5995 Onwards        Pages: 189
    Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, including fevers, retro-orbital pain, severe headache, muscle and joint pain, and rash. The severity of dengue fever ranges......
  • Slovakia Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 113
    BMI View: The Slovakian government is planning to allocate EUR278mn (USD386.7mn) in EU funding to develop healthcare and medical infrastructure in Slovakia over the 2014-2020 period, reports news agency TASR. The government added that after adding contributions from the state budget, the total funds that have been allocated for developing healthcare infrastructure will be EUR300mn (USD417.3mn). The government plans to allocate these funds to projects in large university hospitals and develop......
  • Spain Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 100
    BMI View: The weakened Spanish economy and the government's ongoing multi-faceted strategy to contain expenditure on prescription medicines by targeting patients, companies and the overall healthcare sector present challenges to drugmakers operating in the country. Despite calls made by companies for the implementation of a system that adequately rewards innovation and supports investment in future medicines, the government is likely to remain committed to fiscal consolidation and will conti......
  • Ghana Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 116
    BMI View: Continuing depreciation in the Ghanaian currency has led us to revise our headline forecasts in USD for the pharmaceutical sector downwards. In the long-term however we remain positive for the sector with the government's focus on domestic pharmaceutical sector, greater foreign pharmaceutical company interest in the country and capacity building initiatives for bringing global quality control standards to Ghanaian pharmaceutical industry will spur domestic demand and regional expor......
  • Greece Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 116
    BMI View: The Greek pharmaceutical and healthcare sector will continue contract over the medium-tolong term. Although Greece's financial outlook has stabilised and debts are being paid down, the government will continue to target the pharmaceutical and healthcare industry to reduce public spending. We highlight, however, that the generic drug sector and private healthcare industry will present some growth opportunities in the country. Headline Expenditure Projections ? Pharmaceuticals: EUR......
  • Lithuania Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 97
    BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 3.8%, rising to a value of LTL2.11bn (USD732mn) in 2018. The upcoming switch to the euro promises to boost purchasing power and stabilise the pharmaceutical market, albeit at the cost of increasing healthcare expenditure. Ceding control of monetary policy to Brussels leaves Lithuania with little leeway to increase its healthcare spending dramatically over the next five years. Th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs